Variables | N (%) | P-value | |
---|---|---|---|
Age | |||
≤ 50 years | 117 (34.1) | < 0.001 | |
> 50 years | 21 (70.0) | ||
Sex | |||
Male | 58 (41.4) | 0.169 | |
Female | 80 (34.3) | ||
History of opportunistic infections | |||
Yes | 35 (36.1) | 0.800 | |
No | 103 (37.3) | ||
WHO clinical stage | |||
Stage I/II | 66 (31.1) | 0.007 | |
Stage III/IV | 72 (44.7) | ||
CD4 count | |||
< 200 cells/mm3 | 100 (48.5) | < 0.001 | |
200–350 cell/mm3 | |||
> 350 cells/mm3 | 9 (12.3) | ||
Serum creatinine | |||
> 1.5 mg/dl | 36 (94.7) | < 0.001 | |
≤ 1.5 mg/dl | 102 (30.4) |